
ICON Public Limited Company ICLR
€ 84.72
1.22%
Geschäftsbericht 2024
hinzugefügt 14.02.2026
ICON Public Limited Company Finanzkreislauf 2011-2026 | ICLR
Finanzkreislauf Jährlich ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 62 | 74.2 | 58.1 | 53.1 | 78.5 | 142 | 145 | 132 | 129 | 137 | 132 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 145 | 53.1 | 104 |
Finanzkreislauf Vierteljährlich ICON Public Limited Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 60.2 | - | 45.9 | 63.8 | 66.2 | - | 58.3 | 67.7 | 63.2 | - | 50.2 | 51.9 | 53.2 | - | 54.2 | 56.8 | 56.9 | - | 69.4 | 70.2 | 76.3 | - | 81.6 | 78.8 | 85.7 | - | 83.9 | 82.4 | 85.1 | - | 85.6 | 83.9 | 86.8 | - | 85 | 73.4 | 76 | - | 69.1 | 66.3 | 69.4 | - | 66.6 | 66.4 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 86.8 | 45.9 | 69.4 |
Finanzkreislauf anderer Aktien in der Diagnostik & Forschung
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Trinity Biotech plc
TRIB
|
136 | $ 0.73 | -1.86 % | $ 61.9 M | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
149 | $ 29.0 | -3.07 % | $ 316 M | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
225 | $ 1.14 | -2.16 % | $ 1.45 M | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
299 | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
83.5 | $ 210.56 | -0.33 % | $ 154 B | ||
|
Castle Biosciences
CSTL
|
45.9 | $ 29.41 | -6.17 % | $ 817 M | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Quest Diagnostics Incorporated
DGX
|
38.6 | $ 202.21 | -0.11 % | $ 22.4 B | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
134 | $ 73.08 | 1.11 % | $ 28.5 B | ||
|
DarioHealth Corp.
DRIO
|
207 | $ 11.75 | 2.8 % | $ 333 M | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 18.83 | -5.23 % | $ 1.01 B | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Illumina
ILMN
|
142 | $ 117.53 | -2.06 % | $ 18.7 B | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 23.18 | -0.39 % | $ 701 M | ||
|
Exact Sciences Corporation
EXAS
|
42.5 | $ 103.45 | 0.15 % | $ 19.5 B | ||
|
Lantheus Holdings
LNTH
|
90.9 | $ 74.31 | 1.54 % | $ 5.14 B | ||
|
Guardant Health
GH
|
79.6 | $ 103.36 | -2.84 % | $ 13 B | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
44.9 | $ 1.85 | 2.78 % | $ 8.12 M | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 169.68 | 3.11 % | $ 8.41 B | ||
|
IDEXX Laboratories
IDXX
|
108 | $ 635.6 | 0.77 % | $ 52.4 B | ||
|
IQVIA Holdings
IQV
|
73.9 | $ 166.19 | -1.87 % | $ 28.6 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 31.19 | 0.73 % | $ 20 B | ||
|
Biodesix
BDSX
|
41.7 | $ 13.26 | 4.0 % | $ 1.72 B | ||
|
Quidel Corporation
QDEL
|
68.4 | $ 22.47 | -4.85 % | $ 947 M | ||
|
Laboratory Corporation of America Holdings
LH
|
39.8 | $ 283.38 | 0.32 % | $ 23.8 B | ||
|
Biomerica
BMRA
|
172 | $ 2.17 | -2.25 % | $ 4.98 M | ||
|
Bioventus
BVS
|
208 | $ 8.57 | -0.06 % | $ 537 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 452.99 | 1.47 % | $ 13.1 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
National Research Corporation
NRC
|
33 | $ 13.65 | 9.64 % | $ 335 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 378.44 | 0.14 % | $ 28.4 B |